Dr WORONOFF Anne-Sophie

Fiche personne

Coordonnées

CHRU Besançon
3 bd Fleming
25030 BESANCON Cedex

03 70 63 24 70

Territoire

Franche-Comté

Statut

Chercheur

Recherche

Mots clés : Cancer,Registre de population

Expertises :
- Recherche:Epidémiologie
- Plateforme:Epidémiologie

Projets

Survie et facteurs pronostiques des cancers du col de l'utérus en France : étude en population générale

2017 - Porteur du projet : Dr WORONOFF Anne-Sophie

Caractérisation génétique des mélanomes des extrémités : une étude basée sur la population de Champagne-Ardenne et Franche-Comté (MELEKIT)

2013 - Porteur du projet : Pr GRANGE Florent - Partenaire : Pr AUBIN François , Dr WORONOFF Anne-Sophie

Publications

Surgical patterns of care of pancreatic cancer. A French population-based study.

Goebel G, Jooste V, Molinie F, Grosclaude P, Woronoff AS, Alves A, Bouvier V, Nousbaum JB, Plouvier S, Bengrine-Lefevre L, Rabel T, Bouvier AM,

Eur J Surg Oncol. 2024 10 9;:108748

Vulvar Paget's disease: a population-based cancer registry descriptive study.

Nardin C, Fattet P, Ramanah R, Pretalli JB, Pelletier F, Woronoff AS, Aubin F

J Gynecol Obstet Hum Reprod. 2024 09 1;:102846

Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries.

Gardy J, Wilson S, Guizard AV, Bouvier V, Launay L, Alves A, Bara S, Bouvier AM, Coureau G, Cowppli-Bony A, Dabakuyo Yonli S, Daubisse-Marliac L, Defossez G, Hammas K, Hure F, Jooste V, Lapotre-Ledoux B, Nousbaum JB, Plouvier S, Seigneurin A, Tretarre B, Vigneron N, Woronoff AS, Launoy G, Molinie F, Bryere J, Dejardin O

Cancer. 2024 08 20;:

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer.

El Kaddissi A, Vernerey D, Falcoz A, Mansi L, Bazan F, Chaigneau L, Dobi E, Goujon M, Meneveau N, Paillard MJ, Selmani Z, Viot J, Molimard C, Monnien F, Woronoff AS, Curtit E, Borg C, Meynard G

Clin Breast Cancer. 2024 06 19;:

Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.

Hammas K, Nardin C, Boyer S, Michel C, Aubin F, Woronoff AS

Br J Dermatol. 2024 05 15;:

Socioeconomic Deprivation and Invasive Breast Cancer Incidence by Stage at Diagnosis: A Possible Explanation to the Breast Cancer Social Paradox.

Borghi G, Delacôte C, Delacour-Billon S, Ayrault-Piault S, Dabakuyo-Yonli TS, Delafosse P, Woronoff AS, Trétarre B, Molinié F, Cowppli-Bony A

Cancers (Basel). 2024 04 27;16(9):

Net survival in colon and rectal cancer by stage according to neoadjuvant treatment. A French population-based study.

Jooste V, Grosclaude P, Defossez G, Daubisse L, Woronoff AS, Bouvier V, Chirpaz E, Tretarre B, Lapotre B, Plouvier S, Launoy G, Bonneault M, Molinié F, Bouvier AM,

Dig Liver Dis. 2023 11 3;:

Trends in incidence of invasive vaginal cancer in France from 1990 to 2018 and survival of recently diagnosed women - A population-based study.

Trétarre B, Dantony E, Coureau G, Defossez G, Guizard AV, Delafosse P, Daubisse L, Velten M, Karima Hammas,Barra S, Lapotre B, Plouvier S, d'Almeida T, Molinié F, Woronoff AS

Eur J Obstet Gynecol Reprod Biol. 2023 02 13;283:125-129

Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries.

Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Christensen J, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Walsh PM, Senore C, Rosso S, Lemmens VEPP, Elferink MAG, Tomšič S, Žagar T, Marques ALM, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Sánchez-Gil A, Chirlaque MD, Hoffmeister M, Brenner H

Lancet Reg Health Eur. 2022 10;21:100458

Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol.

Assogba ELF, Dumas A, Woronoff AS, Mollévi C, Coutant C, Ladoire S, Desmoulins I, Dabakuyo-Yonli TS,

BMJ Open. 2022 09 28;12(9):e056834

Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.

Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Tybjerg AJ, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Walsh PM, Senore C, Rosso S, Lemmens VEPP, Elferink MAG, Tomšič S, Žagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Sánchez-Gil A, Chirlaque MD, Hoffmeister M, Brenner H

Lancet Gastroenterol Hepatol. 2022 05 10;:

To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.

Compaoré ZC, Monnet E, Gérazime A, Molinié F, Guizard AV, Delafosse P, Dabakuyo-Yonli TS, Coureau G, Hammas K, Plouvier S, Bara S, Défossez G, Lapôtre-Ledoux B, Daubisse-Marliac L, d'Almeida T, Launoy G, Mansi L, Trétarre B, Woronoff AS

Cancer Causes Control. 2022 Jan 26;:

How do age and social environment affect the dynamics of death hazard and survival in patients with breast or gynecological cancer in France?

Poiseuil M, Tron L, Woronoff AS, Trétarre B, Dabakuyo-Yonli TS, Fauvernier M, Roche L, Dejardin O, Molinié F, Launoy G,

Int J Cancer. 2021 Sep 14;:

Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing.

Defossez G, Uhry Z, Delafosse P, Dantony E, d'Almeida T, Plouvier S, Bossard N, Bouvier AM, Molinié F, Woronoff AS, Colonna M, Grosclaude P, Remontet L, Monnereau A,

BMC Cancer. 2021 Jun 24;21(1):726

Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.

Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T, Májek O, Mužík J, Nilbert MC, Tybjerg AJ, Innos K, Mägi M, Malila N, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Katalinic A, Walsh PM, Senore C, Rosso S, Vincerževskienė I, Lemmens VEPP, Elferink MAG, Johannesen TB, Kørner H, Pfeffer F, Bento MJ, Rodrigues J, Alves da Costa F, Miranda A, Zadnik V, Žagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Chirlaque MD, Ballesta M, Sundquist K, Sundquist J, Weber M, Jordan A, Herrmann C, Mousavi M, Ryzhov A, Hoffmeister M, Brenner H

Lancet Oncol. 2021 May 25;:

Primary cutaneous lymphoma: a population-based cancer registry descriptive study of 155 consecutive cases diagnosed between 1979 and 2016.

Fréchet L, Woronoff AS, Gérazime A, Puzenat E, Dupond AS, Nardin C, Popescu D, Aubin F

Leuk Lymphoma. 2021 Mar 8;:1-6

What is the most appropriate period to define synchronous cancers?

Baicry F, Molinié F, Plouvier S, Colonna M, Daubisse-Marliac L, Grosclaude P, Trétarre B, Bara S, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Marrer E, Klein D, Velten M, Jégu J

Cancer Epidemiol. 2021 Feb 9;71(Pt A):101900

Evaluation of long-term living conditions in patients treated for localised prostate cancer.

Xiao D, Guizard AV, Daubisse-Marliac L, Woronoff AS, Trétarre B, Delafosse P, Molinié F, Cowppli-Bony A, Lapôtre-Ledoux B, Bara S, Marrer E, Velten M, Laroche L, Heutte N, Grosclaude P, Joly F

Eur J Cancer Care (Engl). 2020 Sep 24;:e13333

Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter study.

Bruyere D, Monnien F, Colpart P, Roncarati P, Vuitton L, Hendrick E, Lepinoy A, Luquain A, Pilard C, Lerho T, Molimard C, Maingon P, Arnould L, Bone-Lepinoy MC, Dusserre L, Martin L, Reynders C, Ancion M, Peiffert D, Leroux A, Hubert P, Delhorme JB, Ghnassia JP, Woronoff AS, Delvenne P, Prétet JL, Bosset JF, Peulen O, Mougin C, Valmary-Degano S, Herfs M

Mod. Pathol.. 2020 Jul 29;:

Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival.

Raze T, Lacour B, Cowppli-Bony A, Delafosse P, Velten M, Trétarre B, Defossez G, Hammas K, Woronoff AS, Ganry O, Plouvier S, Coureau G, Guizard AV, Bara S, Monnereau A, Daubisse-Marliac L, Troussard X, D'Almeida T, Baldi I, Bouvier V, Boissel N, Clavel J, Desandes E

J Adolesc Young Adult Oncol. 2020 May 15;:

Angiosarcoma: A population-based cancer registry descriptive study of 45 consecutive cases diagnosed between 1979 and 2016.

Colas M, Gérazime A, Popescu D, Puzenat E, Chaigneau L, Woronoff AS, Dupond AS, Nardin C, Aubin F

Rare Tumors. 2020 ;12:2036361320979216

Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC.

Leroy T, Monnet E, Guerzider S, Jacoulet P, De Bari B, Falcoz PE, Gainet-Brun M, Lahourcade J, Alfreijat F, Almotlak H, Adotevi O, Pernet D, Polio JC, Desmarets M, Woronoff AS, Westeel V

Lung Cancer. 2019 Sep 3;137:23-30

Gastric MALT lymphoma in a population-based study in France: clinical features, treatments and survival.

Matysiak-Budnik T, Jamet P, Ruskoné-Fourmestraux A, de Mascarel A, Velten M, Maynadié M, Woronoff AS, Trétarre B, Marrer E, Delafosse P, Ligier K, Lapôtre Ledoux B, Daubisse L, Bouzid L, Orazio S, Cowppli-Bony A, Monnereau A

Aliment. Pharmacol. Ther.. 2019 Jul 26;:

Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example.

Lamy S, Molinié F, Daubisse-Marliac L, Cowppli-Bony A, Ayrault-Piault S, Fournier E, Woronoff AS, Delpierre C, Grosclaude P

BMC Public Health. 2019 Jul 2;19(1):857

Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy.

Lakkis Z, Vernerey D, Mege D, Faucheron JL, Panis Y, Tuech JJ, Lefevre JH, Brouquet A, Dumont F, Borg C, Woronoff AS, Meurisse A, Heyd B, Rullier E,

Br J Surg. 2019 May 10;:

Occupational exposure to petroleum-based and oxygenated solvents and oral and oropharyngeal cancer risk in men: A population-based case-control study in France.

Barul C, Carton M, Radoï L, Menvielle G, Pilorget C, Woronoff AS, Stücker I, Luce D,

Cancer Epidemiol. 2019 Jan 15;59:22-28

[Implementation of National Cervical Cancer Screening Program in France].

Woronoff AS, Molinié F, Trétarre B

Bull Cancer. 2019 Jan 8;:

Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.

Cowppli-Bony A, Trétarre B, Marrer E, Defossez G, Daubisse-Marliac L, Coureau G, Minicozzi P, Woronoff AS, Delafosse P, Molinié F,

PLoS ONE. 2019 ;14(10):e0224275

Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.

Seigneurin A, Delafosse P, Trétarre B, Woronoff AS, Velten M, Grosclaude P, Guizard AV, Lapôtre-Ledoux B, Bara S, Molinié F, Colonna M

BMC Cancer. 2018 Nov 12;18(1):1091

Adolescent and young adult oncology patients in France: Heterogeneity in pathways of care.

Desandes E, Brugières L, Molinié F, Defossez G, Delafosse P, Jehannin-Ligier K, Velten M, Trétarre B, Amadéo B, Marrer E, Woronoff AS, Ganry O, Monnereau A, d'Almeida T, Troussard X, Daubisse-Marliac L, Bara S, Guizard AV, Baldi I, Launoy G, Clavel J, Lacour B

Pediatr Blood Cancer. 2018 May 17;:e27235

Use of a case-mix approach to study the trends in the incidence of second primary cancers.

Gass B, Marrer E, Bara S, Ligier K, Molinié F, Colonna M, Daubisse-Marliac L, Trétarre B, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Gaiddon C, Klein D, Velten M, Jégu J

Ann Epidemiol. 2018 May;28(5):322-327

Dietary habits during the 2 months following the Chernobyl accident and differentiated thyroid cancer risk in a population-based case-control study.

Xhaard C, Rubino C, Souchard V, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Woronoff AS, Velten M, Marrer E, Bailly L, Mariné Barjoan E, Schlumberger M, Drozdovitch V, Bouville A, Orgiazzi J, Adjadj E, de Vathaire F

Cancer Epidemiol. 2018 Feb;52:142-147

Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey.

Fondain M, Dereure O, Uhry Z, Guizard AV, Woronoff AS, Colonna M, Molinie F, Bara S, Velten M, Marrer E, Grosclaude P, Lapôtre-Ledoux B, Tretarre B, Guillot B

J Eur Acad Dermatol Venereol. 2018 Jan 16;:

Methodological issues of assessing the risk of a second cancer occurring in the same site as a first cancer using registry data.

Jégu J, Moitry M, Bara S, Trétarre B, Guizard AV, Woronoff AS, Daubisse-Marliac L, Bouvier V, Troussard X, Colonna M, Klein D, Lapôtre-Ledoux B, Velten M

Cancer Epidemiol. 2017 12;51:41-43

Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.

Augustin A, Le Gouill S, Gressin R, Bertaut A, Monnereau A, Woronoff AS, Trétarre B, Delafosse P, Troussard X, Moreau A, Hermine O, Maynadié M

J. Cancer Res. Clin. Oncol.. 2017 Oct;:

Occupational exposure to chlorinated solvents and risk of head and neck cancer in men: a population-based case-control study in France.

Barul C, Fayossé A, Carton M, Pilorget C, Woronoff AS, Stücker I, Luce D,

Environ Health. 2017 Jul;16(1):77

Survival of solid cancer patients in France, 1989-2013: a population-based study.

Cowppli-Bony A, Uhry Z, Remontet L, Voirin N, Guizard AV, Trétarre B, Bouvier AM, Colonna M, Bossard N, Woronoff AS, Grosclaude P,

Eur. J. Cancer Prev.. 2017 Jun;:

Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors.

Moitry M, Velten M, Trétarre B, Bara S, Daubisse-Marliac L, Lapôtre-Ledoux B, Troussard X, Molinié F, Ligier K, Woronoff AS, Bouvier V, Colonna M, Klein D, Guizard AV, Jégu J

Cancer Epidemiol. 2017 Apr;47:35-41

Oral cancer characteristics in France: Descriptive epidemiology for early detection.

Jéhannin-Ligier K, Dejardin O, Lapôtre-Ledoux B, Bara S, Coureau G, Grosclaude P, Marrer E, Molinié F, Trétarre B, Velten M, Woronoff AS, Colonna M, Guizard AV

J Stomatol Oral Maxillofac Surg. 2017 Feb;:

Trends in net survival from cervical cancer in six European Latin countries: results from the SUDCAN population-based study.

Haelens A, Roche L, Bastos J, Woronoff AS, Zorzi M, Francart J,

Eur. J. Cancer Prev.. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S92-S99

Are disparities of waiting times for breast cancer care related to socio-economic factors? A regional population-based study (France).

Ayrault-Piault S, Grosclaude P, Daubisse-Marliac L, Pascal J, Leux C, Fournier E, Tagri AD, Métais M, Lombrail P, Woronoff AS, Molinié F

Int. J. Cancer. 2016 Nov;139(9):1983-93

Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.

Neumann F, Jégu J, Mougin C, Prétet JL, Guizard AV, Lapôtre-Ledoux B, Bara S, Bouvier V, Colonna M, Troussard X, Trétarre B, Grosclaude P, Velten M, Woronoff AS

Prev Med. 2016 Sep;90:52-8

Welding, a risk factor of lung cancer: the ICARE study.

Matrat M, Guida F, Mattei F, Cénée S, Cyr D, Févotte J, Sanchez M, Menvielle G, Radoï L, Schmaus A, Woronoff AS, Luce D, Stücker I,

Occup Environ Med. 2016 Apr;73(4):254-61

Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.

Trétarre B, Molinié F, Woronoff AS, Bossard N, Bessaoud F, Marrer E, Grosclaude P, Guizard AV, Delafosse P, Bara S, Velten M, Lapôtre-Ledoux B, Ligier K, Léone N, Arveux P, Uhry Z

Gynecol. Oncol.. 2015 Nov;139(2):324-9

Trends of the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10,047 patients.

Muller J, Grosclaude P, Lapotre-Ledoux B, Woronoff AS, Guizard AV, Bara S, Colonna M, Troussard X, Bouvier V, Tretarre B, Velten M, Jegu J

BJU Int. 2015 Oct 15

Health-related quality of life is a prognostic factor for survival in older patients after colorectal cancer diagnosis: A population-based study.

Fournier E, Jooste V, Woronoff AS, Quipourt V, Bouvier AM, Mercier M

Dig Liver Dis. 2015 Sep 28. pii: S1590-8658(15)00619-2

Impact of rheumatoid arthritis on career progression, productivity, and employability: The PRET Study.

Bertin P, Fagnani F, Duburcq A, Woronoff AS, Chauvin P, Cukierman G, Trope-Chirol S, Joubert JM, Kobelt G

Joint Bone Spine. 2015 Jul 28. pii: S1297-319X(15)00098-6

Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.

Jegu J, Belot A, Borel C, Daubisse-Marliac L, Tretarre B, Ganry O, Guizard AV, Bara S, Troussard X, Bouvier V, Woronoff AS, Colonna M, Velten M

Oral Oncol. 2015 Feb 13. pii: S1368-8375(15)00022-6

Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma.

Rossi C, Jegu J, Mounier M, Dandoit M, Colonna M, Daubisse-Marliac L, Tretarre B, Ganry O, Guizard AV, Bara S, Bouvier V, Woronoff AS, Monnereau A, Casasnovas O, Velten M, Troussard X, Maynadie M

Leuk Lymphoma. 2015 Feb 2:1-23.

Trends in excess mortality in follicular lymphoma at a population level.

Mounier M, Bossard N, Belot A, Remontet L, Iwaz J, Dandoit M, Girard-Boulanger S, Herry A, Woronoff AS, Casasnovas RO, Maynadie M, Giorgi R

Eur J Haematol. 2015 Feb;94(2):120-9

Incidence of chronic myeloid leukemia and patient survival: Results of 5 french population-based cancer registries 1980-2009.

Penot A, Preux P, Le Guyader S, Collignon A, Herry A, Dufour V, Monnereau A, Woronoff A, Troussard X, Pons E, Bordessoule D, Maynadie M

Leuk Lymphoma. 2014 Dec 23:1-38.

Kaposi's sarcoma: a population-based cancer registry descriptive study of 57 consecutive cases diagnosed between 1977 and 2009.

Laresche C, Fournier E, Dupond AS, Woronoff AS, Drobacheff-Thiebaut C, Humbert P, Aubin F

Int J Dermatol. 2014 Dec;53(12):e549-54

Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study.

Voidey A, Pivot X, Woronoff AS, Nallet G, Cals L, Schwetterle F, Limat S

BMC Health Serv Res. 2014 Jul;14:326

Cancer incidence and mortality in France over the 1980-2012 period: solid tumors.

Binder-Foucard F, Bossard N, Delafosse P, Belot A, Woronoff AS, Remontet L

Rev Epidemiol Sante Publique. 2014 Apr;62(2):95-108

Heavy smoking and lung cancer: are women at higher risk? Result of the ICARE study.

Papadopoulos A, Guida F, Leffondre K, Cenee S, Cyr D, Schmaus A, Radoi L, Paget-Bailly S, Carton M, Menvielle G, Woronoff AS, Tretarre B, Luce D, Stucker I

Br J Cancer. 2014 Mar 4;110(5):1385-91

Efficacy of a general practitioner training campaign for early detection of melanoma in France.

Grange F, Woronoff AS, Bera R, Colomb M, Lavole B, Fournier E, Arnold F, Barbe C

Br J Dermatol. 2014 Jan;170(1):123-9

Distinctive features of melanoma and its management in elderly patients: a population-based study in France.

Ciocan D, Barbe C, Aubin F, Granel-Brocard F, Lipsker D, Velten M, Dalac S, Truchetet F, Michel C, Mitschler A, Arnoult G, Buemi A, Dalle S, Bernard P, Woronoff AS, Grange F

JAMA Dermatol. 2013 Oct;149(10):1150-7

[Obstetric outcomes following LOOP-excision].

Baldauf JJ, Baulon E, Thoma V, Woronoff AS, Akladios CY

J Gynecol Obstet Biol Reprod (Paris). 2013 Oct;42(6):534-40

Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.

Crocetti E, Caldarella A, Ferretti S, Ardanaz E, Arveux P, Bara S, Barrios E, Bento MJ, Bordoni A, Buzzoni C, Candela G, Colombani F, Delafosse P, Federico M, Francart J, Giacomin A, Grosclaude P, Guizard AV, Izarzugaza I, Konzelmann I, La Rosa F, Lapotre B, Leone N, Ligier K, Mangone L, Marcos-Gragera R, Martinez R, Michelena MJ, Michiara M, Miranda A, Molinie F, Mugarza-Gomez C, Paci E, Piffer S, Puig-Vives M, Sacchettini C, Sanchez MJ, Traina A, Tretarre B, Tumino R, Van Vaerenbergh E, Velten M, Woronoff AS

Breast. 2013 Aug;22(4):476-81

Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?

Dobi E, Bazan F, Dufresne A, Demarchi M, Villanueva C, Chaigneau L, Montcuquet P, Ivanaj A, Sautiere JL, Maisonnette-Escot Y, Cals L, Algros MP, Woronoff AS, Pivot X

Int J Clin Oncol. 2013 Aug;18(4):607-13

Life expectancy estimates as a key factor in over-treatment: the case of prostate cancer.

Delpierre C, Lamy S, Kelly-Irving M, Molinie F, Velten M, Tretarre B, Woronoff AS, Buemi A, Lapotre-Ledoux B, Bara S, Guizard AV, Colonna M, Grosclaude P

Cancer Epidemiol. 2013 Aug;37(4):462-8

Cancer incidence and survival in adolescents and young adults in France, 2000-2008.

Desandes E, Lacour B, Belot A, Molinie F, Delafosse P, Tretarre B, Velten M, Sauleau EA, Woronoff AS, Guizard AV, Ganry O, Bara S, Grosclaude P, Troussard X, Bouvier V, Brugieres L, Clavel J

Pediatr Hematol Oncol. 2013 May;30(4):291-306

Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.

Monnereau A, Troussard X, Belot A, Guizard AV, Woronoff AS, Bara S, Lapotre-Ledoux B, Iwaz J, Tretarre B, Maynadie M

Int J Cancer. 2013 May 15;132(10):2378-87

Quality of life in long-term cervical cancer survivors: a population-based study.

Le Borgne G, Mercier M, Woronoff AS, Guizard AV, Abeilard E, Caravati-Jouvenceaux A, Klein D, Velten M, Joly F

Gynecol Oncol. 2013 Apr;129(1):222-8

Breast cancer survival in the US and Europe: a CONCORD high-resolution study.

Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, Siesling S, Torrella-Ramos A, Voogd AC, Aareleid T, Ardanaz E, Berrino F, Bielska-Lasota M, Bolick S, Cirilli C, Colonna M, Contiero P, Cress R, Crocetti E, Fulton JP, Grosclaude P, Hakulinen T, Izarzugaza MI, Malmstrom P, Peignaux K, Primic-Zakelj M, Rachtan J, Safaei Diba C, Sanchez MJ, Schymura MJ, Shen T, Traina A, Tryggvadottir L, Tumino R, Velten M, Vercelli M, Wolf HJ, Woronoff AS, Wu X, Coleman MP

Int J Cancer. 2013 Mar 1;132(5):1170-81

Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France.

Grange F, Barbe C, Aubin F, Lipsker D, Granel-Brocard F, Velten M, Dalac S, Truchetet F, Michel C, Mitschler A, Arnoult G, Buemi A, Dalle S, Bernard P, Woronoff AS

Arch Dermatol. 2012 Dec;148(12):1370-6.